Click here to get the latest information on the coronavirus (COVID-19) from Texas HHS.

Drug Use Criteria

The DUR Board provides an evaluation of criteria for drug coverage within Medicaid. HHSC bases the information on the compendia and peer-reviewed medical literature and uses the results in retrospective and prospective drug utilization reviews. Criteria and standards are periodically revised to ensure that they reflect the current compendia and prescribing recommendations.

  1. Acetylcholinesterase Inhibitors
  2. Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs
  3. Aerosolized Agents - Metered-Dose Inhalers: Anti-inflammatory Drugs
  4. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting)
  5. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting)
  6. Angiotensin-Converting Enzyme Inhibitors
  7. Angiotensin II Receptor Blockers
  8. Anti-depressants, oral (other)
  9. Anti-depressants, selective serotonin reuptake inhibitors
  10. Anti-diabetic Agents (oral)
  11. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
  12. Atypical Anti-psychotics (long-acting injectable)
  13. Atypical Anti-psychotics (oral)
  14. Benzodiazepines (oral, rectal)
  15. Complement Inhibitor and Enzyme/Protein Replacement Therapy
  16. Cyclooxygenase-2 Inhibitors
  17. Direct Oral Anticoagulants
  18. Exogenous Insulin Products
  19. Fentanyl
  20. Fluoroquinolones (oral)
  21. Gabapentin
  22. Glucagon-like Peptide 1 Receptor Agonists
  23. Histamine H2 - Receptor Antagonists
  24. Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors
  25. Hydrocodone Bitartrate/Hydrocodone Polistirex
  26. Immune Globulins
  27. Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi)
  28. Ketorolac (oral)
  29. Leukotriene Receptor Antagonists
  30. Low Molecular - Weight Heparins
  31. Mecasermin
  32. Memantine
  33. Nebulized Bronchodilators
  34. Nitazoxanide
  35. Non-sedating Antihistamines
  36. Non-steroidal anti-inflammatory drugs
  37. Platelet Aggregation Inhibitors
  38. Pramlintide
  39. Promethazine Use In Children Less Than 2 Years of Age
  40. Proton Pump Inhibitors
  41. Quetiapine (low dose)
  42. Rifaximin (Xifaxan)
  43. Sedative/Hypnotics
  44. Serotonin 5-HT1B/1D Receptor Agonists
  45. Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral)
  46. Sickle Cell Disease Products
  47. Skeletal Muscle Relaxants
  48. Substance P/Neurokinin1 Receptor Antagonists
  49. Topical Calcineurin Inhibitors - Pimecrolimus (Elidel) and Tacrolimus (Protopic)
  50. Tramadol

Resources